Brian Czerniecki Department of Breast Oncology H. Lee Moffitt Cancer Center & Research Institute Biography Publications Institution JoVE Articles Brian Czerniecki has not added a biography. If you are Brian Czerniecki and would like to personalize this page please email our Author Liaison for assistance. Publications Th1 Cytokine Interferon Gamma Improves Response in HER2 Breast Cancer by Modulating the Ubiquitin Proteasomal Pathway Molecular Therapy : the Journal of the American Society of Gene Therapy. Jan, 2021 | Pubmed ID: 33412308 Immunotherapy in Breast Cancer: Current Status and Future Directions Advances in Cancer Research. 2019 | Pubmed ID: 31202361 Vaccine Therapies for Breast Cancer Surgical Oncology Clinics of North America. 07, 2019 | Pubmed ID: 31079793 Immunotherapy for Breast Cancer is Finally at the Doorstep: Immunotherapy in Breast Cancer Annals of Surgical Oncology. Oct, 2018 | Pubmed ID: 30014455 Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2017 | Pubmed ID: 27965306 Anti-HER2 CD4 T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer Annals of Surgical Oncology. Apr, 2017 | Pubmed ID: 27826664 Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes Annals of Surgical Oncology. Feb, 2017 | Pubmed ID: 27663569 A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease Vincent Law1,2, Margi Baldwin3, Ganesan Ramamoorthi4, Krithika Kodumudi4, Nam Tran1, Inna Smalley5, Derek Duckett6, Pawel Kalinski7, Brian Czerniecki4, Keiran S. M. Smalley2, Peter A. Forsyth1,2 1Department of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, 2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, 3Department of Comparative Medicine, University of South Florida, 4Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute, 5Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, 6Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, 7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center JoVE 62033 Cancer Research
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease Vincent Law1,2, Margi Baldwin3, Ganesan Ramamoorthi4, Krithika Kodumudi4, Nam Tran1, Inna Smalley5, Derek Duckett6, Pawel Kalinski7, Brian Czerniecki4, Keiran S. M. Smalley2, Peter A. Forsyth1,2 1Department of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, 2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, 3Department of Comparative Medicine, University of South Florida, 4Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute, 5Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, 6Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, 7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center JoVE 62033 Cancer Research